Abstract
African and African-American (AA) women have higher incidence of triple-negative breast cancers (TNBC) with high histological grade and aggressive clinical behavior, but the reasons are not fully understood. We recently found that the oncogenic protein EZH2 is overexpressed in Ghanaian breast cancer patients, with 16% of the tumors expressing cytoplasmic EZH2. Understanding the molecular underpinnings of these aggressive tumors may lead to the identification of potential targetable oncogenic drivers. We characterized the copy number variations of 11 Ghanaian breast tumor patients by targeted multiplexed PCR-based DNA next-generation sequencing (NGS) over 130 cancer-relevant genes. While the DNA quality was not optimal for mutation analysis, 90% of the tumors had frequent recurrent copy number alterations (CNAs) of 17 genes: SDHC, RECQL4, TFE3, BCL11A, BCL2L1, PDGFRA, DEK, SMUG1, AKT3, SMARCA4, VHL, KLF6, CCNE1, G6PD, FGF3, ABL1, and CCND1, with the top oncogenic functions being mitotic G1-G1/S-phase regulation, gene transcription, apoptosis, and PI3K/AKT pathway. The most common recurrent high-level CNAs were gains of RECQL4 and SDHC, in 50% and 60% of cases, respectively. Network analyses revealed a significant predicted inter...Continue Reading
References
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Dec 20, 2002·Cancer·Vickie L ShaversJennifer L Stevens
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Jan 6, 2005·The Oncologist·Lisa A Newman
Mar 16, 2005·Cancer·Alero Fregene, Lisa A Newman
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ingeborg M BachmannLars A Akslen
Oct 17, 2006·BMC Cancer·Anne LetessierMax Chaffanet
Apr 3, 2007·Nature Genetics·Julius GudmundssonKari Stefansson
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghui GuanJoe W Gray
Feb 12, 2008·Nature Genetics·Rosalind A EelesDouglas F Easton
Dec 17, 2008·Oncogene·M E GonzalezC G Kleer
Aug 8, 2009·The American Journal of Pathology·Xin LiCelina G Kleer
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dezheng HuoOlufunmilayo I Olopade
Jul 16, 2010·Cancer·Azadeh StarkLisa Newman
Sep 24, 2010·Molecular Endocrinology·Daniel J Toft, Vincent L Cryns
Jan 11, 2011·Cancer Cell·Chun-Ju ChangMien-Chie Hung
Mar 17, 2011·Cancer Research·Maria E GonzalezCelina G Kleer
Oct 13, 2011·Cancer·Wei CaoWantao Chen
Apr 25, 2012·Breast Cancer Research and Treatment·Judy PangCelina G Kleer
Jul 31, 2013·PloS One·Hongbo FangYongliang Zhao
Jun 3, 2014·Surgical Oncology Clinics of North America·Prasanna Alluri, Lisa A Newman
Sep 26, 2014·PLoS Genetics·Alessio IannettiNeil D Perkins
Jan 17, 2015·Molecular Cancer Research : MCR·Andi K CaniScott A Tomlins
Mar 6, 2015·Clinical and Experimental Pharmacology & Physiology·Muyang DingYane Gao
Mar 7, 2015·Annals of Surgical Oncology·Erica ProctorLisa Newman
May 1, 2015·Neoplasia : an International Journal for Oncology Research·Daniel H HovelsonScott A Tomlins
Dec 23, 2015·The Journal of Pathology·Arvind AroraSrinivasan Madhusudan
Mar 16, 2017·Molecular Cancer Therapeutics·Elayne Chan-PenebreScott A Ribich
Apr 1, 2017·BMC Cancer·Tuukka VeijaVirinder Kaur Sarhadi
May 5, 2017·JAMA Oncology·Dezheng HuoOlufunmilayo I Olopade
Jul 19, 2017·Journal of Global Oncology·Evelyn JiaggeBaffour Awuah
Oct 27, 2017·Journal of Clinical Pathology·Alessandro Pietro Aldera, Dhirendra Govender
May 8, 2018·The Journal of Pathology·Jinfeng CaoMartine J Jager
Jul 20, 2018·Nature Communications·Talha AnwarCelina G Kleer
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal